Search research articles
Contact Us
Filters
Showing results (191-200 of 306) with videos related to
Page
of 31
Sort By:
Oncology
|
February 23, 2016
Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma
Hideo Kunimoto, Kenji Ikeda, Yushi Sorin, et al.
Hepatology Communications
|
May 18, 2022
Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study
Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.
Journal of Medical Virology
|
August 24, 2006
Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C
Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 21, 2010
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer
Kenji Ikeda, Masahiro Kobayashi, Yuya Seko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 5, 2011
Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model
Kenji Ikeda, Masahiro Kobayashi, Yusuke Kawamura, et al.
Intervirology
|
April 7, 2005
Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: comparison with breakthrough hepatitis during long-term treatment
Norio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Intervirology
|
March 4, 2010
Extending combination therapy with peginterferon plus ribavirin for genotype 2 chronic hepatitis C virological responders: a pilot study of 7 cases
Norio Akuta, Fumitaka Suzuki, Yasuji Arase, et al.
Journal of Gastroenterology and Hepatology
|
February 20, 2009
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
Yoshiyuki Suzuki, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 1, 2009
Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Internal Medicine (Tokyo, Japan)
|
August 19, 2009
The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2
Yasuji Arase, Fumitaka Suzuki, Hitomi Sezaki, et al.
Page
of 31
Search research articles
Search
Showing results (191-200 of 306) with videos related to
Sort By:
Page
of 31
Oncology
|
February 23, 2016
Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma
Hideo Kunimoto, Kenji Ikeda, Yushi Sorin, et al.
Hepatology Communications
|
May 18, 2022
Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study
Norio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.
Journal of Medical Virology
|
August 24, 2006
Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C
Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 21, 2010
Administration of interferon for two or more years decreases early stage hepatocellular carcinoma recurrence rate after radical ablation: A retrospective study of hepatitis C virus-related liver cancer
Kenji Ikeda, Masahiro Kobayashi, Yuya Seko, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
April 5, 2011
Stage progression of small hepatocellular carcinoma after radical therapy: comparisons of radiofrequency ablation and surgery using the Markov model
Kenji Ikeda, Masahiro Kobayashi, Yusuke Kawamura, et al.
Intervirology
|
April 7, 2005
Virological and biochemical relapse after discontinuation of lamivudine monotherapy for chronic hepatitis B in Japan: comparison with breakthrough hepatitis during long-term treatment
Norio Akuta, Fumitaka Suzuki, Mariko Kobayashi, et al.
Intervirology
|
March 4, 2010
Extending combination therapy with peginterferon plus ribavirin for genotype 2 chronic hepatitis C virological responders: a pilot study of 7 cases
Norio Akuta, Fumitaka Suzuki, Yasuji Arase, et al.
Journal of Gastroenterology and Hepatology
|
February 20, 2009
Efficacy of entecavir treatment for lamivudine-resistant hepatitis B over 3 years: histological improvement or entecavir resistance?
Yoshiyuki Suzuki, Fumitaka Suzuki, Yusuke Kawamura, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 1, 2009
Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi, et al.
Internal Medicine (Tokyo, Japan)
|
August 19, 2009
The efficacy of interferon-beta monotherapy for elderly patients with type C hepatitis of genotype 2
Yasuji Arase, Fumitaka Suzuki, Hitomi Sezaki, et al.
Page
of 31